Oncolytics data show reovirus may boost immune system

By Elaine Rigoli

Tampa, Fla., Sept. 8 - Oncolytics Biotech, Inc. said a poster entitled "Reovirus Activates Dendritic Cells (DC) and Promotes Innate Anti-Tumour Immunity" will be held at the Joint Meeting of European National Societies of Immunology in Paris this week.

The Calgary, Alta.-based biotechnology company said the poster highlights the researchers' use of isolated human cells to examine whether the use of the reovirus as a direct tumor-killing agent might also activate the innate immune system to play a role in the killing of tumor cells.

These results suggest that in addition to direct cancer cell killing, the reovirus may assist the immune system in fighting cancer cells, officials noted.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.